Myriam Gwerder

680 total citations
9 papers, 519 citations indexed

About

Myriam Gwerder is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Myriam Gwerder has authored 9 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Myriam Gwerder's work include Glycosylation and Glycoproteins Research (2 papers), DNA Repair Mechanisms (2 papers) and T-cell and B-cell Immunology (2 papers). Myriam Gwerder is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), DNA Repair Mechanisms (2 papers) and T-cell and B-cell Immunology (2 papers). Myriam Gwerder collaborates with scholars based in Switzerland, Germany and Canada. Myriam Gwerder's co-authors include Roger R. Beerli, Martin F. Bachmann, Regula B. Buser, Simone Muntwiler, Monika Bauer, Manuel Stucki, Philippe Saudan, Patrik Maurer, Daniel Fink and Armelle Corpet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Myriam Gwerder

9 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myriam Gwerder Switzerland 8 364 126 115 94 58 9 519
Chris Herring United Kingdom 4 428 1.2× 228 1.8× 95 0.8× 66 0.7× 24 0.4× 5 594
W. Mark Abbott United Kingdom 13 439 1.2× 128 1.0× 86 0.7× 71 0.8× 31 0.5× 23 606
Lesley A. Pearce Australia 14 330 0.9× 272 2.2× 119 1.0× 94 1.0× 77 1.3× 22 577
M. Welin Sweden 13 363 1.0× 47 0.4× 84 0.7× 47 0.5× 53 0.9× 30 551
Stephen Kerby United States 10 400 1.1× 46 0.4× 105 0.9× 69 0.7× 69 1.2× 15 603
Sandrine Guillard United Kingdom 11 580 1.6× 88 0.7× 126 1.1× 44 0.5× 32 0.6× 12 714
Jason Borawski United States 9 459 1.3× 112 0.9× 59 0.5× 193 2.1× 65 1.1× 11 648
Monika Anand United States 12 541 1.5× 36 0.3× 82 0.7× 83 0.9× 58 1.0× 14 705
Vasantharajan Janakiraman United States 7 408 1.1× 51 0.4× 88 0.8× 85 0.9× 19 0.3× 8 462
F Ghani United States 4 170 0.5× 89 0.7× 96 0.8× 61 0.6× 35 0.6× 8 397

Countries citing papers authored by Myriam Gwerder

Since Specialization
Citations

This map shows the geographic impact of Myriam Gwerder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Gwerder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Gwerder more than expected).

Fields of papers citing papers by Myriam Gwerder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriam Gwerder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Gwerder. The network helps show where Myriam Gwerder may publish in the future.

Co-authorship network of co-authors of Myriam Gwerder

This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Gwerder. A scholar is included among the top collaborators of Myriam Gwerder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Gwerder. Myriam Gwerder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meier‐Abt, Fabienne, Junyan Lu, Ester Cannizzaro, et al.. (2021). The protein landscape of chronic lymphocytic leukemia. Blood. 138(24). 2514–2525. 19 indexed citations
2.
Berg, Regina, Christoph G. W. Gertzen, Katja Zerbe, et al.. (2020). Semisynthetic Analogs of the Antibiotic Fidaxomicin—Design, Synthesis, and Biological Evaluation. ACS Medicinal Chemistry Letters. 11(12). 2414–2420. 17 indexed citations
3.
Samartzis, Eleftherios Pierre, Aurelia Noske, Adriana von Teichman, et al.. (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE. 9(6). e100041–e100041. 71 indexed citations
4.
Larsen, Dorthe Helena, Julie A. Clapperton, Myriam Gwerder, et al.. (2014). The NBS1–Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology. 16(8). 792–803. 125 indexed citations
5.
Corpet, Armelle, Teresa Olbrich, Myriam Gwerder, Daniel Fink, & Manuel Stucki. (2013). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle. 13(2). 249–267. 55 indexed citations
6.
Schmitz, Nicole, Monika Bauer, Heather Hinton, et al.. (2009). Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+regulatory T cells. Proceedings of the National Academy of Sciences. 106(28). 11673–11678. 46 indexed citations
7.
Beerli, Roger R., Monika Bauer, Nicole Schmitz, et al.. (2009). Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein. Virology Journal. 6(1). 224–224. 37 indexed citations
8.
Bauer, Monika, Klaus Dietmeier, Regula B. Buser, et al.. (2008). Identification of Ly-6K as a novel marker for mouse plasma cells. Molecular Immunology. 45(10). 2727–2733. 6 indexed citations
9.
Beerli, Roger R., Monika Bauer, Regula B. Buser, et al.. (2008). Isolation of human monoclonal antibodies by mammalian cell display. Proceedings of the National Academy of Sciences. 105(38). 14336–14341. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026